An official website of the United States government
Supporting research in human populations to understand determinants of cancer occurrence and outcomes and translating findings to clinical and public health interventions.
Funding Opportunities
Impacts of Climate Change Across he Cancer Control Continuum
PAR-23-153 (R01 - Clinical Trial Optional) and PAR-23-152 (R21 - Clinical Trial Optional)
Expires May 8, 2026
Pragmatic Trials Across the Cancer Control Continuum
PAR-22-256 (UG3/UH3 - Clinical Trial Required)
Expires November 18, 2025
for this funding opportunity.
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility
PAR-22-083 (R01 - Clinical Trial Not Allowed) and PAR-22-084 (R21 - Clinical Trial Not Allowed)
Expires May 8, 2025
Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts
PAR-22-161 (U01 - Clinical Trial Not Allowed)
Expires March 1, 2025
.
Research Opportunities in Established Cancer Epidemiology Cohort Studies
PAR-22-162 (U01 - Clinical Trial Not Allowed)
Expires March 1, 2025
.
Notice of Special Interest: Technology Development for Cancer Control and Population Science Research
NOT-CA-23-037
Expires December 31, 2024
Exploratory Grants in Cancer Control
PAR-21-341 (R21 - Clinical Trial Optional)
Expires October 9, 2024
Time-Sensitive Obesity Policy and Program Evaluation
PAR-21-305 (R01 - Clinical Trial Not Allowed)
Expires September 11, 2024
Notice of Special Interest: Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research
NOT-CA-22-037
Expires March 9, 2024
Modular R01s in Cancer Control and Population Sciences
PAR-21-190 (R01 - Clinical Trial Optional)
Expires March 8, 2024
Notice of Special Interest: Understanding the Effects of Cancer and Cancer Treatment on Aging Trajectories and Aging Outcomes
NOT-CA-21-031
Expires January 8, 2024
Assay Validation of High Quality Markers for Clinical Studies in Cancer
PAR-20-313 (UH2/UH3 - Clinical Trial Not Allowed) and PAR-20-314 (UH3 - Clinical Trials Not Allowed)
Expires October 11, 2023
Liver Cancer Collaborative Projects with the Liver Cirrhosis Network
RFA-CA-23-023 (U01, Clinical Trial Optional)
Expires June 3, 2023
Featured Resource
Registration Open for June 2023 Workshop
The joint NIEHS-NCI workshop, Molecular Signatures of Exposure in Cancer, will assess the current state of the science of using signatures from “omic” data types to link environmental exposures to cancer and explore potential uses of such signatures of carcinogenic exposure to aid cancer prevention. This virtual workshop will be held June 29-30, 2023.
Featured Event
Save the date for the 2023 Meeting
The 2023 Cohort Consortium Annual Meeting will be held on October 11-13, 2023 at the NCI Shady Grove campus in Rockville, MD and will be a hybrid in-person/virtual format. More information is forthcoming.
The 2022 Cohort Consortium Annual Meeting was held virtually on November 1-2, 2022. Materials from the meeting such as information about the speakers, the meeting materials, and the recordings will remain available on the website. Please visit the website for more information.
What's New
Connect With Us
Subscribe for Updates
Subscribe
You can subscribe and unsubscribe at any time by entering your email address and selecting your preferences on the page that follows.
Need Help?
EGRP staff can answer questions on grant funding, policies, and research resources. If you do not know who to contact we will do our best to connect you with someone who can help you.
Email Us(240) 276-6730